⚖

Compare Funds

See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.

MF
—Nippon India Flexi Cap Fund - Growth - Direct PlanDirect · Growth
₹16.77 as on 30 Oct 2026
VS
HD
HDFC MFHDFC Pharma and Healthcare Fund - Growth - Direct PlanDirect · Growth
₹21.95 as on 30 Oct 2026
▤Key Metrics Comparison
MetricMFNippon India Flexi Cap Fund - Growth - Direct PlanHDHDFC Pharma and Healthcare Fund - Growth - Direct Plan
Snapshot
AMC—HDFC MF
CategoryEquity - Flexi Cap FundEquity - Sectoral Fund - Pharma & Health Care
NAV₹16.77 (30 Oct 2026)₹21.95 (30 Oct 2026)
Rating★★★★★★★
BenchmarkNIFTY 500 - TRIBSE Health Care - TRI
Fund ManagerMeenakshi DawarNikhil Mathur
Inception13 Aug 202104 Oct 2023
Returns
1Y-7.82%22.64%
3Y9.38%30.41%
5Y9.47%—
Since Inception10.49%29.15%
Risk
14.4114.07
1.020.59
0.261.59
-0.2121.67
0.473.48
-11.94%-9.23%
Costs
Expense Ratio0.65%1.03%
Exit LoadNil upto 10% of units and 1% for remaining investments on or before 12M, Nil after 12M1% on or before 30D, Nil after 30D
Min SIP₹100₹100
Min Lumpsum₹500₹100
Lock-inNoneNone

Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.

◐Portfolio Overlap
Nippon India …100%
HDFC MF100%
0.0%

Only 0.0% of holdings by weight are common between Nippon India Flexi Cap Fund - Growth - Direct Plan and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.

Category context: Equity vs Equity. Open the full Screener →